Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

UN-recognised scholar awarded the prestigious TRI Annual PhD Award
2015-11-09

Dr Anneli Botha, winner of TRI Award for Best Doctoral Thesis.
Photo: Supplied

Two years after enrolling as a PhD candidate in the University of the Free State’s (UFS) Department of Political Studies and Governance, Dr Anneli Botha was awarded the annual Terrorism Research Initiative (TRI) Award for the 'Best Doctoral Thesis on Terrorism and Counter-Terrorism' (2014).

The TRI PhD award is a prestigious international honour, while terrorism as a scholarly venture remains a concentrated field. Dr Botha, one of the few women in this niche field, has proved to be an excellent asset. Her winning of the prestigious award was announced in its October 2015 issue of Perspectives on Terrorism (PT), a globally-circulated online journal, co-published by the European-based Terrorism Research Initiative and the America-based Center for Terrorism and Security Studies.

Based on the merit and relevance of her outstanding research, the United Nations Development Programme has appointed Dr Botha as a Consultant on Radicalisation. In addition, her PhD is to be published as a book in the United States of America early in 2016. She was appointed as a Research Associate at the University of the Free State at the beginning of this year.

An award-winning search for answers

Her thesis, titled “Radicalisation to Terrorism in Kenya and Uganda: a Political Socialisation Perspective”, tackled East African militancy, from an individualised perspective. Researchers in the past have neglected assessing details of the rebels’ childhoods. Dr Botha’s interviewed about 285 militants and their families. These individuals declared themselves openly as members of al-Shabaab and the Mombasa Republican Council (MRC) in Kenya, and the Allied Democratic Forces (ADF) and the Lord’s Resistance Army (LRA) in Uganda, at the time of the interviews.

Her doctoral dissertation provides significant information about factors that should be considered in the quest to counter and prevent terrorism. Her research shows conclusively that political socialisation begins with the family, and expands through peers, school, media, and earlier political experiences, culminating in the terrorist group.

Outstanding piece of scholarship

Dr Alex Schmid
, who is the editor of PT, TRI Award Jury chairman, and one of the most respected experts of terrorism, described Dr Botha’s research as an “outstanding piece of scholarship.”

Dr Botha attributed her success to her supervisors - Professors Theo Neethling and Hussein Solomon - as well as to the people in Kenya and Uganda.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept